Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023-Reference-Cited by-同舟云学术

Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023

Published:2024-01-11 Issue:2 Volume:29 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Gong Cheng¹²³,Huang Fang¹²³,Suo Luodan²³,Guan Xuejiao³,Kang Lu²³,Xie Hui³,Hu Geng³,Yang Peng²³,Wang Quanyi²³

Affiliation:

1. These authors contributed equally to this study

2. Beijing Research Center for Respiratory Infectious Diseases, Beijing, People’s Republic of China

3. Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China

Abstract

In 2023, through an ongoing respiratory pathogen surveillance system, we observed from mid-September onwards, an increase of respiratory illness among children aged ≤ 15 years presenting at hospital outpatient clinics in Beijing, China. Data indicated that illness was caused by multiple pathogens, predominantly Mycoplasma pneumoniae. Seasonality, periodicity and high prevalence of resistance to macrolide (30 of 30 strains sequenced with the A2063G mutation) were important characteristics of the M. pneumoniae epidemic, which resulted in a rise in consultations at specialised paediatric hospitals.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference13 articles.

1. World Health Organization (WHO). WHO statement on reported clusters of respiratory illness in children in northern China. Geneva: WHO; 2023-11-22. Available from: https://www.who.int/news/item/22-11-2023-who-statement-on-reported-clusters-of-respiratory-illness-in-children-in-northern-china

2. Distribution of the atypical pathogens of community-acquired pneumonia to disease severity.;Gong;J Thorac Dis,2018

3. Genetic diversity and epidemiological features of respiratory syncytial virus, Beijing, 2015-2019: A multicenter and all-age groups study.;Luo;J Infect,2022

4. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020.;Wang;Emerg Microbes Infect,2022

5. World Health Organization (WHO). WHO surveillance case definitions for ILI and SARI. Geneva: WHO; January 2014. Available from: https://cdn.who.int/media/docs/default-source/influenza/who_ili_sari_case_definitions_2014.pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What we learned from the infection control and what we need in the future: A quantitative and qualitative study on hospital infection prevention and control practitioners (HIPCPs) in Tianjin, China;American Journal of Infection Control;2024-09

2. Population-Based Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection in Southern China, 2023–2024 Season;Open Forum Infectious Diseases;2024-08-21

3. Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China;Frontiers in Cellular and Infection Microbiology;2024-08-16

4. Wastewater Surveillance Uncovered the Impacts of the Timing of COVID-19 on the Epidemic Trajectories of Other Respiratory Diseases in Two Northeastern Cities in China;ACS ES&T Water;2024-08-14

5. Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic;Virology Journal;2024-08-11